MetaCap

CareDx (CDNA) vs Clover Health Investments (CLOV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CareDx (CDNA) has outperformed Clover Health Investments (CLOV) over the past year, gaining 307.5% versus a gain of 63.6%. Over five years, CDNA leads with a +65.2% price change compared with -31.1% for CLOV. CareDx is the larger company by market cap ($3.68 billion vs $2.00 billion), about 1.8 times the size, while Clover Health Investments is growing revenue faster (+40.3% vs +13.8%).

On valuation, Clover Health Investments trades at a lower forward P/E (20.7x vs 44.7x for CareDx). Clover Health Investments converts more of its revenue into profit, with a net margin of -4.4% versus -5.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDNA+307.45%CLOV+63.60%
+437%+195%-47%
Nov 21, 20251 yearNov 20, 2026
CDNA+62.75%CLOV-35.13%
+113%+7%-99%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDNA versus CLOV key metrics
MetricCDNACLOV
Share price$70.00$3.73
Market cap$3.68B$2.00B
1-day change-2.67%-1.06%
YTD return+271.55%+58.72%
1-year return+307.45%+63.60%
5-year return+65.21%-31.05%
P/E ratio (TTM)29.54373.00
Forward P/E44.7520.72
EPS (TTM)$2.37$0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$379.81M$1.92B
Revenue growth (YoY)+13.79%+40.34%
Net income (latest FY)$-21.35M$-85.55M
Operating margin-8.10%-4.44%
Net margin-5.62%-4.45%
52-week high$90.87$5.59
52-week low$15.56$1.58
Distance from 52-week high-22.97%-33.27%
Analyst consensusbuybuy
Avg. price target upside+34.90%+50.13%
Average volume1.30M4.49M
Shares outstanding52.54M439.71M
Employees761724
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CDNA has outperformed CLOV by 243.9 percentage points over the past year.
  • Clover Health Investments trades at a higher earnings multiple (373.0x vs 29.5x trailing P/E).
  • Clover Health Investments grew revenue faster in its latest fiscal year (+40.34% vs +13.79%).

About CareDx

CDNA stock →

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Health Care · Medical Specialities · 761 employees

About Clover Health Investments

CLOV stock →

Clover Health Investments, Corp. provides medicare advantage plans in the United States.

Health Care · Medical Specialities · 724 employees

CDNA vs CLOV FAQ

Which is bigger, CareDx or Clover Health Investments?

CareDx (CDNA) is larger, with a market capitalization of $3.68B compared with $2.00B for Clover Health Investments (CLOV).

Which stock has performed better over the past year, CDNA or CLOV?

CDNA returned +307.45% over the past 12 months, compared with +63.60% for CLOV (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CDNA or CLOV?

CDNA has the lower trailing P/E at 29.5, versus 373.0 for CLOV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are CareDx and Clover Health Investments in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons